A New Decade Of Outsourcing: What Can We Expect? - Advice from Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen
Source: Outsourced Pharma
Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.
Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."
Here are excerpts from the opening comments of one of our speakers,Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
This website uses cookies to ensure you get the best experience on our website. Learn more